Oncology & Cancer

CRISPR genome editing and immunotherapy – the early adopter

It's been a couple of years since the genome editing tool CRISPR first hit the headlines. And talk of its potential to cure all manner of diseases, create superhumans and bring dinosaurs back from the dead has followed.

Oncology & Cancer

New findings on obesity and response to cancer therapy

Liza Makowski, Ph.D., professor in the Department of Medicine and the UTHSC Center for Cancer Research, has long been interested in how the immune system is altered by obesity and how this impacts cancer risk and treatment.

Oncology & Cancer

Drug may slow spread of deadly eye cancer

A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to researchers at Washington University School of Medicine in St. Louis.

page 8 from 40